Aurobindo cleared to market Baraclude generic
DAYTON, N.J. — Aurobindo Pharma Ltd. has gained approval from the Food and Drug Administration for entecavir tablets 0.5 mg and 1 mg, a medication for hepatitis B. Aurobindo, which announced the product this week, said its entecavir tablets are a generic version of Baraclude tablets (0.5 mg and 1 mg) from Bristol-Myers Squibb. Entecavir tablets